Latest News
PRESS RELEASES
Join Accelera at the Safety Pharmacology Society (SPS) in Edinburgh!
Edinburgh, UK
September 19-21, 2007
Stop by booth # 70 to learn more about Accelera's unique platform of interested ADME/PK, safety pharmacology, and toxicology service offerings, and for the chance to win the latest in Ferrari merchandise!
Accelera is able to offer a complete "core battery" package of regulatory Safety Pharmacology studies. Employing state-of-the-art technology for data collection, analysis and storage, all studies are GLP (21 CFR part 11) compliant and designed in line with the latest regulatory guidelines.
To assess cardiovascular/QT liabilities of new compounds while still in a discovery setting, Accelera also offers a range of in silico, in vitro, and in vivo Safety Pharmacology studies.
ACCELERA WILL ALSO BE PRESENTING THE
FOLLOWING POSTERS:
When: Thursday 20 September
Where: CROMDALE HALL, LEVEL -2
If you would like more information on Safety Pharmacology services at Accelera, or other services we provide, please visit our website at www.accelera.info or contact us at info@accelera.info
For further information regarding the SPS congress: www.safetypharmacology.org
Edinburgh, UK
September 19-21, 2007
Stop by booth # 70 to learn more about Accelera's unique platform of interested ADME/PK, safety pharmacology, and toxicology service offerings, and for the chance to win the latest in Ferrari merchandise!
Accelera is able to offer a complete "core battery" package of regulatory Safety Pharmacology studies. Employing state-of-the-art technology for data collection, analysis and storage, all studies are GLP (21 CFR part 11) compliant and designed in line with the latest regulatory guidelines.
To assess cardiovascular/QT liabilities of new compounds while still in a discovery setting, Accelera also offers a range of in silico, in vitro, and in vivo Safety Pharmacology studies.
ACCELERA WILL ALSO BE PRESENTING THE
FOLLOWING POSTERS:
When: Thursday 20 September
Where: CROMDALE HALL, LEVEL -2
Poster # 57
Title: SOTALOL as Positive Control for IKR
block in HEK-293 Cells and for QT
Prolungation in Conscious Monkeys and
Dogs
Authors: V. Perego, C. Arrigoni, C. Cavazzoli
Title: SOTALOL as Positive Control for IKR
block in HEK-293 Cells and for QT
Prolungation in Conscious Monkeys and
Dogs
Authors: V. Perego, C. Arrigoni, C. Cavazzoli
Poster # 28
Title: Evaluation of Long Term Effects of an
Intracardiac Implant for ECG recording
in Conscious Monkeys
Authors: C. Arrigoni, F. Carù, U. Bonfanti,
C. Guglielmini, C. Cavazzoli, V. Perego,
B. Rosa, M. Anelli
Title: Evaluation of Long Term Effects of an
Intracardiac Implant for ECG recording
in Conscious Monkeys
Authors: C. Arrigoni, F. Carù, U. Bonfanti,
C. Guglielmini, C. Cavazzoli, V. Perego,
B. Rosa, M. Anelli
Poster # 58
Title: Heart Rate Correction of the QT
interval: a nonparametric
individualized approach
Authors: G. Greco, A. Russu, C. Arrigoni,
P. Magni, G. De Nicolao, M. Rocchetti
Title: Heart Rate Correction of the QT
interval: a nonparametric
individualized approach
Authors: G. Greco, A. Russu, C. Arrigoni,
P. Magni, G. De Nicolao, M. Rocchetti
If you would like more information on Safety Pharmacology services at Accelera, or other services we provide, please visit our website at www.accelera.info or contact us at info@accelera.info
For further information regarding the SPS congress: www.safetypharmacology.org
